| Dendritic‐cell‐specific ICAM3‐grabbing non‐integrin is essential for the productive infection of human dendritic cells by mosquito‐cell‐derived dengue viruses E Navarro‐Sanchez, R Altmeyer, A Amara, O Schwartz, F Fieschi, ... EMBO reports 4 (7), 723-728, 2003 | 683 | 2003 |
| Multivalent glycoconjugates as anti-pathogenic agents A Bernardi, J Jiménez-Barbero, A Casnati, C De Castro, T Darbre, ... Chemical Society Reviews 42 (11), 4709-4727, 2013 | 578 | 2013 |
| DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2 PY Lozach, H Lortat-Jacob, ADL De Lavalette, I Staropoli, S Foung, ... Journal of Biological Chemistry 278 (22), 20358-20366, 2003 | 527 | 2003 |
| Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection F Halary, A Amara, H Lortat-Jacob, M Messerle, T Delaunay, C Houlès, ... Immunity 17 (5), 653-664, 2002 | 483 | 2002 |
| Inactivation of ribonucleotide reductase by nitric oxide M Lepoivre, F Fieschi, J Coves, L Thelander, M Fontecave Biochemical and biophysical research communications 179 (1), 442-448, 1991 | 462 | 1991 |
| NADPH oxidase activator p67phox behaves in solution as a multidomain protein with semi-flexible linkers D Durand, C Vivès, D Cannella, J Pérez, E Pebay-Peyroula, P Vachette, ... Journal of structural biology 169 (1), 45-53, 2010 | 326 | 2010 |
| NADPH oxidases (NOX): an overview from discovery, molecular mechanisms to physiology and pathology A Vermot, I Petit-Härtlein, SME Smith, F Fieschi Antioxidants 10 (6), 890, 2021 | 315 | 2021 |
| Chromophore twisting in the excited state of a photoswitchable fluorescent protein captured by time-resolved serial femtosecond crystallography N Coquelle, M Sliwa, J Woodhouse, G Schirò, V Adam, A Aquila, ... Nature Chemistry 10 (1), 31-37, 2018 | 188 | 2018 |
| Crystal Structure of the Rac1−RhoGDI Complex Involved in NADPH Oxidase Activation, S Grizot, J Faure, F Fieschi, PV Vignais, MC Dagher, E Pebay-Peyroula Biochemistry 40 (34), 10007-10013, 2001 | 184 | 2001 |
| DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist M Thépaut, J Luczkowiak, C Vivès, N Labiod, I Bally, F Lasala, Y Grimoire, ... PLoS pathogens 17 (5), e1009576, 2021 | 166 | 2021 |
| Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation S Sattin, A Daghetti, M Thepaut, A Berzi, M Sanchez-Navarro, G Tabarani, ... ACS chemical biology 5 (3), 301-312, 2010 | 148 | 2010 |
| DC-SIGN neck domain is a pH-sensor controlling oligomerization: SAXS and hydrodynamic studies of extracellular domain G Tabarani, M Thépaut, D Stroebel, C Ebel, C Vivès, P Vachette, ... Journal of biological chemistry 284 (32), 21229-21240, 2009 | 148 | 2009 |
| The mechanism and substrate specificity of the NADPH: flavin oxidoreductase from Escherichia coli (∗) F Fieschi, V Niviere, C Frier, JL Décout, M Fontecave Journal of Biological Chemistry 270 (51), 30392-30400, 1995 | 146 | 1995 |
| NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action V Jaquet, J Marcoux, E Forest, KG Leidal, S McCormick, Y Westermaier, ... British journal of pharmacology 164 (2b), 507-520, 2011 | 144 | 2011 |
| Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding G Tabarani, JJ Reina, C Ebel, C Vivès, H Lortat-Jacob, J Rojo, F Fieschi FEBS letters 580 (10), 2402-2408, 2006 | 140 | 2006 |
| A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus N Varga, I Sutkeviciute, R Ribeiro-Viana, A Berzi, R Ramdasi, A Daghetti, ... Biomaterials 35 (13), 4175-4184, 2014 | 131 | 2014 |
| Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection J Luczkowiak, S Sattin, I Sutkeviciute, JJ Reina, M Sánchez-Navarro, ... Bioconjugate chemistry 22 (7), 1354-1365, 2011 | 117 | 2011 |
| 1, 2‐Mannobioside mimic: synthesis, DC‐SIGN interaction by NMR and docking, and antiviral activity JJ Reina, S Sattin, D Invernizzi, S Mari, L Martínez‐Prats, G Tabarani, ... ChemMedChem: Chemistry Enabling Drug Discovery 2 (7), 1030-1036, 2007 | 111 | 2007 |
| The active N-terminal region of p67phox: structure at 1.8 Å resolution and biochemical characterizations of the A128V mutant implicated in chronic granulomatous disease S Grizot, F Fieschi, MC Dagher, E Pebay-Peyroula Journal of Biological Chemistry 276 (24), 21627-21631, 2001 | 111 | 2001 |
| Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods S Ordanini, N Varga, V Porkolab, M Thépaut, L Belvisi, A Bertaglia, ... Chemical communications 51 (18), 3816-3819, 2015 | 101 | 2015 |
F Javier Rojo MarcosInvestigador Científico del CSICVerified email at iiq.csic.es
